|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
4
|
|
pubmed:dateCreated |
1999-9-22
|
|
pubmed:abstractText |
Accelerated bone loss is a well-recognized complication after cardiac transplantation (HTx) due to immunosuppressive therapy. The purpose of this prospective, longitudinal, randomized, placebo-controlled, double-blind study was to investigate the effect of calcitriol (1,25-dihydroxyvitamin D3) in the prevention of bone loss and fracture rate after HTx.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Aug
|
|
pubmed:issn |
0041-1337
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
27
|
|
pubmed:volume |
68
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
523-30
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:10480411-Adult,
pubmed-meshheading:10480411-Bone Density,
pubmed-meshheading:10480411-Calcitriol,
pubmed-meshheading:10480411-Calcium, Dietary,
pubmed-meshheading:10480411-Estrogens,
pubmed-meshheading:10480411-Female,
pubmed-meshheading:10480411-Heart Transplantation,
pubmed-meshheading:10480411-Humans,
pubmed-meshheading:10480411-Immunosuppressive Agents,
pubmed-meshheading:10480411-Longitudinal Studies,
pubmed-meshheading:10480411-Male,
pubmed-meshheading:10480411-Middle Aged,
pubmed-meshheading:10480411-Osteoporosis,
pubmed-meshheading:10480411-Prospective Studies,
pubmed-meshheading:10480411-Testosterone
|
|
pubmed:year |
1999
|
|
pubmed:articleTitle |
Prevention of osteoporosis after cardiac transplantation: a prospective, longitudinal, randomized, double-blind trial with calcitriol.
|
|
pubmed:affiliation |
Medizinische Klinik, Klinikum Innenstadt, Department of Cardiology, Ludwig-Maximilians University, Munich, Germany.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|
